Eagle Forum Legislative Alerts

Tuesday, August 17, 2010

US breast cancer drug decision 'marks start of death panels'

America's health watchdog is considering revoking its approval of the drug Avastin for use on women with advanced breast cancer, leading to accusations that it will mark the start of 'death panel' drug rationing.

A decision to rescind endorsement of the drug would reignite the highly charged debate over US health care reform and how much the state should spend on new and expensive treatments.
Avastin, the world’s best selling cancer drug, is primarily used to treat colon cancer and was approved by the US Food and Drug Administration in 2008 for use on women with breast cancer that has spread.

Read more of this story

No comments:

Post a Comment

Keep comments short. Long comments will be deleted.